Contrast injector technology firm Medrad of Warrendale, PA, signed a research agreement with the University of Zurich to study dynamic PET imaging with the Medrad Intego PET infusion system.
The researchers will utilize Medrad's technology to control the radioactive dose delivered during PET imaging procedures.
Specifically, the study will examine patients with tumors in the chest or abdomen and will compare standard quantitative techniques, such as standardized uptake value, with more advanced kinetic and compartmental models.
Related Reading
Medrad partners with Wetsco, November 14, 2008
Road to RSNA, MRI, Medrad, October 31, 2008
Road to RSNA, CT, Medrad, October 29, 2008
Confirma, Medrad partner, August 27, 2008
FDA clears Medrad's wireless MR infusion system, August 12, 2008
Copyright © 2009 AuntMinnie.com
